Senate committee advances package to tighten oversight of IDD providers after emotional testimony

Trenton — The Senate Health, Human Services and Senior Citizens Committee on Wednesday advanced a multi‑bill package intended to strengthen oversight, transparency and enforcement of services for people with intellectual and developmental disabilities (IDD).

Sarah Adleman, Commissioner of the Department of Human Services, told the committee that the package would give the agency new tools to hold providers accountable for systemic failures, citing authority to impose financial penalties, to terminate payment authorization for chronically noncompliant providers and to create a director of medical services to improve medical oversight and investigations. "This bill package would empower us to hold providers accountable for those systemic failures," Adleman said in testimony.

The bills include provisions to: authorize a medical director position to advise and support abuse and mortality investigations; establish a Disability Mortality and Abuse Prevention Advisory Committee; require an annual workforce survey of Division of Developmental Disabilities service providers; and expand financial‑transparency and governance standards for providers, including limits on administrative spending and maximums on executive compensation.

Provider groups urged caution. Tom Bufuto, executive director of The Arc of New Jersey, said the organization supports stronger oversight but warned the legislation could produce unintended consequences, particularly S3752’s proposed 15% cap on administrative costs. "Providers will need to divert critical resources and funding away from ensuring quality ... if these fines go into place," Bufuto said, asking senators to review proposed fines and caps and consider amendments.

Valerie Sellers, CEO of the New Jersey Association of Community Providers, and other provider witnesses said the bills as drafted risked destabilizing service capacity under the state’s fee‑for‑service system and could force providers to reduce services or exit the market. Several providers and trade associations urged more stakeholder engagement and targeted changes rather than sweeping caps.

Family members and advocates gave emotionally charged testimony about failures in investigations and care. Paul Aronson, New Jersey’s ombudsman for individuals with IDD, recommended independent investigative capacity and stronger mortality reviews; parent advocates recounted deaths and lapses in care and urged the committee to strengthen investigative mechanisms and safeguards. "Abuse and neglect occur in group homes that are understaffed," Aronson said, urging measures on staffing, transparency and independence of investigations.

Committee members pressed the administration on timelines and details. Adleman defended a 180‑day requirement in one bill that would require providers to complete internal investigations, noting that the state’s average investigation timeline is about 130 days and that law enforcement inquiries can lengthen review times.

After several hours of testimony, the committee voted to release multiple bills as amended for further consideration. The clerk read motions and roll calls for the measures, recording release votes on S3753 (medical director), S3754 (advisory committee), S3755 (receivership framework), S3756 (workforce survey) and other related measures.

The hearing made clear the bills’ goals — tighter oversight, stronger investigation and greater financial transparency — remain a point of agreement across many witnesses, even as providers and families differed sharply on whether the proposed remedies would improve or impair services. The committee invited additional written testimony from those who could not speak and said deliberations would continue as the bills move through the legislative process.

The committee released the bills as amended; they will proceed to the next procedural step in the legislative process.